TaiMed Biologics (ROCO:4147) Price-to-Operating-Cash-Flow : 265.05 (As of May. 26, 2024)

View and export this data going back to 2010. Start your Free Trial

What is TaiMed Biologics Price-to-Operating-Cash-Flow?

As of today (2024-05-26), TaiMed Biologics's share price is NT$87.20. TaiMed Biologics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was NT$0.33. Hence, TaiMed Biologics's Price-to-Operating-Cash-Flow Ratio for today is 265.05.

The historical rank and industry rank for TaiMed Biologics's Price-to-Operating-Cash-Flow or its related term are showing as below:

ROCO:4147' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 252.28 Med: 263.99 Max: 285.71
Current: 265.05

During the past 13 years, TaiMed Biologics's highest Price-to-Operating-Cash-Flow Ratio was 285.71. The lowest was 252.28. And the median was 263.99.

ROCO:4147's Price-to-Operating-Cash-Flow is ranked worse than
96.21% of 290 companies
in the Biotechnology industry
Industry Median: 26.275 vs ROCO:4147: 265.05

TaiMed Biologics's Cash Flow from Operations per share for the three months ended in Mar. 2024 was NT$0.11. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was NT$0.33.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 49.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 35.40% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 7.80% per year.

During the past 13 years, TaiMed Biologics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 49.80% per year. The lowest was -55.30% per year. And the median was 4.60% per year.

TaiMed Biologics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for TaiMed Biologics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TaiMed Biologics Price-to-Operating-Cash-Flow Chart

TaiMed Biologics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

TaiMed Biologics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	266.87

Competitive Comparison of TaiMed Biologics's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, TaiMed Biologics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TaiMed Biologics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TaiMed Biologics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where TaiMed Biologics's Price-to-Operating-Cash-Flow falls into.

TaiMed Biologics Price-to-Operating-Cash-Flow Calculation

TaiMed Biologics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	87.20	/	0.329
	=	265.05

TaiMed Biologics's Share Price of today is NT$87.20.
TaiMed Biologics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.33.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

TaiMed Biologics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of TaiMed Biologics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

TaiMed Biologics (ROCO:4147) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiMed Biologics Inc (ROCO:4147) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 607, Ruiguang Road, 3rd Floor, Neihu District, Taipei, TWN, 11492

Website

http://www.taimedbiologics.com

TaiMed Biologics Inc is a Taiwan-based biotechnology company. It is engaged in the discovery, development, and delivery of medicines for infectious disease. It capitalizes on its intellectual, extensive expertise, and management resources to develop a health-care product pipeline that benefits patients, rewards investors, and propels to prominence in the biotechnology industry. The company's products pipeline includes TMB-365, VRC07-523LS, and others.

TaiMed Biologics (ROCO:4147) Headlines

No Headlines